NON-SMALL CELL LUNG CANCERS
Clinical trials for NON-SMALL CELL LUNG CANCERS explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCERS trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer drug combo study halted early after only 6 patients
Disease control TerminatedThis study tested a new drug (PRT3789) combined with an immunotherapy (pembrolizumab) in people with advanced solid tumors that have a specific genetic change called SMARCA4 mutation. The goal was to see if the combination was safe and could shrink tumors. The study was terminate…
Matched conditions: NON-SMALL CELL LUNG CANCERS
Phase: PHASE2 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated May 17, 2026 07:03 UTC
-
Cancer drug cocktail trial halted after just one patient
Disease control TerminatedThis early-stage study aimed to see if combining two targeted drugs, adagrasib and olaparib, was safe for people with advanced solid tumors that have a KRAS G12C mutation. The trial focused on certain cancers like lung, breast, pancreatic, and gynecological cancers. However, the …
Matched conditions: NON-SMALL CELL LUNG CANCERS
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 06:52 UTC